Mass Tort Update

Mass Tort Update

Here is an update on a number of mass tort cases in the news:

Zantac

In February, the U.S. Judicial Panel on Multidistrict Litigation sent Zantac cases to the Southern District of Florida in what could be extensive litigation regarding the heartburn medication. Plaintiffs in these cases allege that Zantac can produce a cancer-causing agent called n-nitrosodimethylamine (NDMA), and they have developed cancer as a result of long-term use of the drug. NDMA has been linked to a number of different cancers, including:

  • Prostate cancer
  • Liver cancer
  • Lower esophageal cancer
  • Non-Hodgkins lymphoma
  • Leukemia
  • Multiple myeloma
  • Colon cancer
  • Stomach cancer
  • Intestinal cancer
  • Pancreatic cancer

Further studies are being performed on NDMA and may link other cancers to the substance.

Roundup

A trial in the Roundup weed killer lawsuits was postponed pending settlement negotiations between the plaintiffs and manufacturer Bayer. The plaintiffs allege that they developed non-Hodgkin’s lymphoma as a result of using Roundup, whose active ingredient is a probable carcinogen called glyphosate. In March, a lawsuit was filed by multiple groups against the Environmental Protection Agency who re-approved the use of glyphosate in Roundup weed killer. The lawsuit alleges that the EPA ignored the warnings of scientists, environmentalists, and medical experts when it renewed its approval. Bayer, the company that purchased Roundup manufacturer Monsanto, is facing backlash from its investors over the purchase. Investors cite the fact that the Roundup lawsuit will likely result in billions of dollars in settlement.

Juul 

E-cigarette manufacturer Juul has been facing multiple lawsuits across the country alleging that the company focused its marketing on teens and young adults. This resulted in thousands of teenagers using their e-cigarette products and becoming injured as a result. Now 39 states have entered into an agreement to investigate the company and their marketing practices. Juul controls 75% of the vaping market, and pressure from this multi-state investigation could lead to serious settlement negotiations and the possibility of a universal settlement.

Due to the coronavirus, Juul and other e-cigarette manufacturers have been given an extension on the deadline for submitting their products for review by the FDA. The deadline has been moved from May 12th to September 9th.

Contact an Experienced Mass Torts Attorney

If you’ve been injured by a dangerous or defective product, you should consult with an experienced product liability attorney. Gregg Goldfarb has been helping the victims of dangerous products for over 20 years. Contact us online or call us at 305-374-7000 to schedule a free consultation.

Previous Post
Electronic Logging Devices Can Help Prevent Truck Accidents
Next Post
Establishing a Link Between Whistleblowing and Your Termination
Menu